Epizyme reported $5.9M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Abbott ABT:US $ 7179M 692M
Agios Pharmaceuticals AGIO:US $ 5.9M 1.53M
Amarin AMRN:US $ 110.23M 53.42M
Amgen AMGN:US $ 5077M 182M
Avrobio Inc AVRO:US 2.84M 147K
Biogen BIIB:US $ 2021.4M 59.7M
Cerulean Pharma CERU:US $ 1.73M 584.53K
Daiichi Sankyo 4568:JP Y 266675M 16204M
Eisai 4523:JP Y 207950M 6650M
Epizyme EPZM:US $ 5.9M 670K
Exelixis EXEL:US $ 190.61M 92.04M
Gilead Sciences GILD:US $ 3787M 706M
GlaxoSmithKline GSK:LN 8.8B 451M
Glaxosmithkline GSK:US $ 8797M 451M
Karyopharm Therapeutics KPTI:US $ 24.99M 2.5M
Macrogenics MGNX:US $ 14.9M 4.52M
Merk MRK:US $ 9828M 598M
Mirati Therapeutics MRTX:US $ 1.81M 0.7M
Novartis NOVN:VX 8.68B 395M
Novartis NVS:US $ 8678M 395M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Seattle Genetics SGEN:US $ 401.01M 11.75M
Spectrum Pharmaceuticals SPPI:US $ 0.64M 0.39M
Vertex Pharmaceuticals VRTX:US $ 1292.8M 156M
Xencor XNCR:US $ 93.2M 26.82M